|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Geng F, Wang Z, Yin H, Yu J and Cao B:
Molecular targeted drugs and treatment of colorectal cancer: Recent
progress and future perspectives. Cancer Biother Radiopharm.
32:149–160. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Roelands J, Kuppen PJK, Vermeulen L,
Maccalli C, Decock J, Wang E, Marincola FM, Bedognetti D and
Hendrickx W: Immunogenomic Classification of Colorectal Cancer and
Therapeutic Implications. Int J Mol Sci. 18:22292017. View Article : Google Scholar
|
|
5
|
Su M, Xiao Y, Ma J, Tang Y, Tian B, Zhang
Y, Li X, Wu Z, Yang D, Zhou Y, et al: Circular RNAs in cancer:
Emerging functions in hallmarks, stemness, resistance and roles as
potential biomarkers. Mol Cancer. 18:902019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cheng J, Zhuo H, Xu M, Wang L, Xu H, Peng
J, Hou J, Lin L and Cai J: Regulatory network of circRNA-miRNA-mRNA
contributes to the histological classification and disease
progression in gastric cancer. J Transl Med. 16:2162018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dori M and Bicciato S: Integration of
bioinformatic predictions and experimental data to identify
circRNA-miRNA associations. Genes (Basel). 10:6422019. View Article : Google Scholar
|
|
9
|
Wu J, Chen Z, Song Y, Zhu Y, Dou G, Shen
X, Zhou Y, Jiang H, Li J and Peng Y: CircRNA_0005075 suppresses
carcinogenesis via regulating miR-431/p53/epithelial-mesenchymal
transition axis in gastric cancer. Cell Biochem Funct. 38:932–942.
2020. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Q, Chen Z, Cao S, Guo B, Chen Y, Feng
Z, Wang J, Guo G, Chen X and Huang X: Role of CircRNAs_100395 in
proliferation and metastases of liver cancer. Med Sci Monit.
25:6181–6192. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li L, Yu P, Zhang P, Wu H, Chen Q, Li S
and Wang Y: Upregulation of hsa_circ_0007874 suppresses the
progression of ovarian cancer by regulating the miR-760/SOCS3
pathway. Cancer Med. 9:2491–2499. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao J, Li L, Wang Q, Han H, Zhan Q and Xu
M: CircRNA expression profile in early-stage lung adenocarcinoma
patients. Cell Physiol Biochem. 44:2138–2146. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao J and Liu XS: Circular RNA 0060428
sponges miR-375 to promote osteosarcoma cell proliferation by
upregulating the expression of RPBJ. Gene. 740:1445202020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu Q, Dai J and Shu M: Retraction:
Hsa_circ_0003645 shows an oncogenic role by sponging microRNA-1299
in hepatocellular carcinoma cells. J Clin Lab Anal. 34:e232492020.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qian L, Guan J, Wu Y and Wang Q:
Upregulated circular RNA circ_0074027 promotes glioblastoma cell
growth and invasion by regulating miR-518a-5p/IL17RD signaling
pathway. Biochem Biophys Res Commun. 510:515–519. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao P, Wang Z, Hu Z, Jiao X and Yao Y:
Circular RNA circ_0074027 indicates a poor prognosis for NSCLC
patients and modulates cell proliferation, apoptosis, and invasion
via miR-185-3p mediated BRD4/MADD activation. J Cell Biochem.
121:2632–2642. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng X, Zhang L, Zhang K, Zhang G, Hu Y,
Sun X, Zhao C, Li H, Li YM and Zhao J: Circular RNA VMA21 protects
against intervertebral disc degeneration through targeting miR-200c
and X linked inhibitor-of-apoptosis protein. Ann Rheum Dis.
77:770–779. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu JZ, Shao CC, Wang XJ, Zhao X, Chen JQ,
Ouyang YX, Feng J, Zhang F, Huang WH, Ying Q, et al: circTADA2As
suppress breast cancer progression and metastasis via targeting
miR-203a-3p/SOCS3 axis. Cell Death Dis. 10:1752019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu W, Han Q, Zhao L and Wang L: Circular
RNA circRNA_15698 aggravates the extracellular matrix of diabetic
nephropathy mesangial cells via miR-185/TGF-β1. J Cell Physiol.
234:1469–1476. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ng WL, Mohd Mohidin TB and Shukla K:
Functional role of circular RNAs in cancer development and
progression. RNA Biol. 15:995–1005. 2018.PubMed/NCBI
|
|
22
|
Bachmayr-Heyda A, Reiner AT, Auer K,
Sukhbaatar N, Aust S, Bachleitner-Hofmann T, Mesteri I, Grunt TW,
Zeillinger R and Pils D: Correlation of circular RNA abundance with
proliferation-exemplified with colorectal and ovarian cancer,
idiopathic lung fibrosis, and normal human tissues. Sci Rep.
5:80572015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qu S, Yang X, Li X, Wang J, Gao Y, Shang
R, Sun W, Dou K and Li H: Circular RNA: A new star of noncoding
RNAs. Cancer Letts. 365:141–148. 2015. View Article : Google Scholar
|
|
24
|
Yu C, Ying J, Yu K, Shen W and Jiang M:
Circ_0074027 contributes to nonsmall cell lung cancer progression
by upregulating CUL4B expression through miR-335-5p. Cancer Biother
Radiopharm. Jun 22–2020.(Epub ahead of print). doi:
10.1089/cbr.2020.3579. View Article : Google Scholar
|
|
25
|
Moch H, Sauter G, Gasser TC, Buchholz N,
Bubendorf L, Richter J, Jiang F, Dellas A and Mihatsch MJ: p53
protein expression but not mdm-2 protein expression is associated
with rapid tumor cell proliferation and prognosis in renal cell
carcinoma. Urol Res. 25 (Suppl 1):S25–S30. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jaber S, Toufektchan E, Lejour V, Bardot B
and Toledo F: p53 downregulates the Fanconi anaemia DNA repair
pathway. Nat Commun. 7:110912016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rossi F, Legnini I, Megiorni F, Colantoni
A, Santini T, Morlando M, Di Timoteo G, Dattilo D, Dominici C and
Bozzoni I: Circ-ZNF609 regulates G1-S progression in
rhabdomyosarcoma. Oncogene. 38:3843–3854. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Su W, Sun S, Wang F, Shen Y and Yang H:
Circular RNA hsa_circ_0055538 regulates the malignant biological
behavior of oral squamous cell carcinoma through the
p53/Bcl-2/caspase signaling pathway. J Transl Med. 17:762019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thiery JP, Acloque H, Huang RYJ and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brabletz T, Kalluri R, Nieto MA and
Weinberg RA: EMT in cancer. Nat Rev Cancer. 18:128–134. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Derynck R and Weinberg RA: EMT and cancer:
More than meets the eye. Dev Cell. 49:313–316. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Z, Li Y, Kong D and Sarkar FH: The
role of Notch signaling pathway in epithelial-mesenchymal
transition (EMT) during development and tumor aggressiveness. Curr
Drug targets. 11:745–751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hu H, Hu S, Xu S, Gao Y, Zeng F and Shui
H: miR-29b regulates Ang II-induced EMT of rat renal tubular
epithelial cells via targeting PI3K/AKT signaling pathway. Int J
Mol Med. 42:453–460. 2018.PubMed/NCBI
|
|
35
|
Wang T and Wang X, Du Q, Wu N, Liu X, Chen
Y and Wang X: The circRNA circP4HB promotes NSCLC aggressiveness
and metastasis by sponging miR-133a-5p. Biochem Biophys Res Commun.
513:904–911. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wei S, Zheng Y, Jiang Y, Li X, Geng J,
Shen Y, Li Q, Wang X, Zhao C, Chen Y, et al: The circRNA circPTPRA
suppresses epithelial-mesenchymal transitioning and metastasis of
NSCLC cells by sponging miR-96-5p. EBioMedicine. 44:182–193. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zheng Q, Bao C, Guo W, Li S, Chen J, Chen
B, Luo Y, Lyu D, Li Y, Shi G, et al: Circular RNA profiling reveals
an abundant circHIPK3 that regulates cell growth by sponging
multiple miRNAs. Nat Commun. 7:112152016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fu X, Zhang J, He X, Yan X, Wei J, Huang
M, Liu Y, Lin J, Hu H and Liu L: Circular RNA MAN2B2 promotes cell
proliferation of hepatocellular carcinoma cells via the
miRNA-217/MAPK1 axis. J Cancer. 11:3318–3326. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wong CH, Lou UK, Li Y, Chan SL, Tong JHM,
To KF and Chen Y: CircFOXK2 promotes growth and metastasis of
pancreatic ductal adenocarcinoma by complexing with RNA binding
proteins and sponging MiR-942. Cancer Res. 80:2138–2149. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pang F, Zha R, Zhao Y, Wang Q, Chen D,
Zhang Z, Chen T, Yao M, Gu J and He X: MiR-525-3p enhances the
migration and invasion of liver cancer cells by downregulating
ZNF395. PLoS One. 9:e908672014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Paydas S, Acikalin A, Ergin M, Celik H,
Yavuz B and Tanriverdi K: Micro-RNA (miRNA) profile in Hodgkin
lymphoma: Association between clinical and pathological variables.
Med Oncol. 33:342016. View Article : Google Scholar : PubMed/NCBI
|
